Trial finds new drug safe, effective to treat deadliest form of epilepsy
MSN highlights UC trial data presentation
MSN highlighted research presented by the University of Cincinnati’s Brandon Foreman that found ganaxolone is a safe and effective treatment for refractory status epilepticus, the most severe and deadly form of epilepsy where seizures do not stop.
Current standards of care include administering an intravenous antiseizure medicine, a benzodiazepine such as midazolam, as soon as possible to stop seizures. When those do not work, a second intravenous antiseizure medication is started, but about one quarter of patients continue to experience seizures, termed refractory status epilepticus (RSE).
The Phase 3 RAndomized Therapy In Status Epilepticus (RAISE) trial tested a neurosteroid called ganaxolone for patients hospitalized with seizures that progressed to RSE despite receiving two or more antiseizure medications.
Researchers found a statistically significant proportion of patients who received ganaxolone stopped seizing within 30 minutes: 80% of those patients receiving ganaxolone saw their RSE stop a median of just 4 minutes after the drug was administered.
“Ganaxolone as a rapidly effective medication would fill a specific gap in care for which there are no current treatment options beyond intubation and anesthetic medications if standard antiseizure medications fail,” he said. “It is recognized that the use of anesthetics increases the morbidity and mortality of RSE, so ganaxolone has the potential to save lives and avoid prolonged intensive care.”
Featured photo at top of Foreman looking at a brain monitor. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
Cincinnati sees record rainfall in weekend deluge
July 21, 2026
The Cincinnati Enquirer talks to UC College of Engineering and Applied Science Associate Professor Patrick Ray for context about a July 17 rainstorm that dumped a record amount of rain on parts of Cincinnati.
Putting preschool into perspective
July 20, 2026
Preschool and childcare can be difficult to navigate for parents, as Spectrum News 1 Ohio recently reported. Waitlists are long, and factors like cost, location and transportation can limit options. According to a recent study published by The Annie E. Casey Foundation, only 41% of 3- to 4-year-olds in Ohio were enrolled in preschool between 2020 and 2024 — a 4% decrease from pre-pandemic numbers. For University of Cincinnati early childhood education faculty member Chad Nunamaker, that statistic has caveats.
Engineering magnets for a cleaner future
July 20, 2026
The United States is heavily reliant on imported rare-earth materials to make permanent magnets. Ugochukwu Philip Ochieze, materials science student at the University of Cincinnati, is studying how to use common materials to create permanent magnets, eliminating the need for expensive and scarce rare-earth materials. Pursuing his PhD, Ochieze was named Graduate Student Engineer of the Month by the College of Engineering and Applied Science.